New Autism Treatments Target :"Innate Pathogens" Causing Focal Brain Inflammation
Our recent evidence indicates that mitochondria, known for their energy production, break up and move to the cell surface where they secrete their ATP and DNA. These are misconstrued by the body as “innate pathogens” leading to an inflammatory response affecting specific brain regions responsible for behavior and language. Luteolin inhibits these processes and has a significant benefit in autism.
Theoharis C. Theoharides
Theoharis C. Theoharides, MPhil, PhD, MD, FAAAAI
He received all degrees from Yale, trained in internal medicine and received an Award “recognizing excellence, compassion and service.” He has 350 publications and 15,000 citations. He is Director of the Molecular Immunopharmacology and Drug Discovery Laboratory, as well as a Professor of Pharmacology, Biochemistry and Internal Medicine, Tufts University, Boston, MA
